The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase

被引:165
|
作者
Cooper, CE
Lynagh, GR
Hoyes, KP
Hider, RC
Cammack, R
Porter, JB
机构
[1] UCL, SCH MED, DEPT HAEMATOL, LONDON WC1E 6HX, ENGLAND
[2] UNIV LONDON KINGS COLL, DIV LIFE SCI, MET BIOL & MED CTR, LONDON W8 7AH, ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1074/jbc.271.34.20291
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The depletion of cellular iron can lead to the inhibition of ribonucleotide reductase, preventing new DNA synthesis and hence inhibiting cell proliferation. Electron paramagnetic resonance (EPR) spectroscopy has been used to examine simultaneously for the first time the relationship between chelation of intracellular iron and the rate of removal and regeneration of the tyrosyl radical of ribonucleotide reductase within intact human leukemia K562 cells. The different physiochemical characteristics of relatively hydrophobic low molecular weight bidentate hydroxypyridinone chelators and the higher molecular weight hexadentate ferrioxamine have been exploited to elucidate these interactions further. The base-line concentration of EPR detectable mononuclear nonheme iron complexes was 3.15 +/- 1.05 mu M, rising on incubation with chelators more rapidly with hydroxypyridinones than with desferrioxamine. Hydroxypyridinones also removed the tyrosyl radical more rapidly, apparently as a consequence of depletion of the intracellular iron pools necessary to regenerate the active enzyme and compatible with their reportedly greater cell toxicity. The radical decay rate is consistent with previous models, suggesting that iron is spontaneously removed from mammalian ribonucleotide reductase. Upon removal of extracellular chelator the regeneration of the tyrosyl radical was significantly faster for hydroxypyridinones than for desferrioxamine, consistent with their differential effects on cell cycle synchronization.
引用
收藏
页码:20291 / 20299
页数:9
相关论文
共 50 条
  • [31] RIBONUCLEOTIDE REDUCTASE - SUBSTRATE + METAL INTERACTIONS AND INHIBITION BY THIOSEMICARBAZONES
    MOORE, EC
    AGRAWAL, KC
    SARTORELLI, AC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 160 - 160
  • [32] INHIBITION OF RIBONUCLEOTIDE REDUCTASE BY A FLAVONE (QUERCETIN) AND A HYDROXYQUINONE (LAPACHOL)
    SMITH, SL
    DOUGLAS, KT
    IRCS MEDICAL SCIENCE-BIOCHEMISTRY, 1986, 14 (06): : 541 - 542
  • [33] ACYCLOVIRS ANTIHERPETIC ACTIVITY IS POTENTIATED BY INHIBITION OF RIBONUCLEOTIDE REDUCTASE
    SPECTOR, T
    AVERETT, DR
    NELSON, DJ
    LAMBE, CU
    MORRISON, RW
    STCLAIR, MH
    FURMAN, PA
    PEDIATRIC RESEARCH, 1985, 19 (07) : 778 - 778
  • [34] IRREVERSIBLE INHIBITION OF RIBONUCLEOTIDE REDUCTASE BY A MODULATOR ANALOG OF ATP
    CORY, JG
    GEORGE, CB
    FEDERATION PROCEEDINGS, 1973, 32 (03) : 576 - &
  • [35] Role of the C terminus of the ribonucleotide reductase large subunit in enzyme regeneration and its inhibition by Sml1
    Zhang, Zhen
    Yang, Kui
    Chen, Chin-Chuan
    Feser, Jason
    Huang, Mingxia
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (07) : 2217 - 2222
  • [36] STUDIES ON THE DIFFERENTIAL MECHANISMS OF INHIBITION OF RIBONUCLEOTIDE REDUCTASE BY SPECIFIC INHIBITORS OF THE NON-HEME IRON SUBUNIT
    SATO, A
    BACON, PE
    CORY, JG
    ADVANCES IN ENZYME REGULATION, 1984, 22 : 231 - 241
  • [37] RIBONUCLEOTIDE REDUCTASE ISOLATED FROM HUMAN CELLS
    CHANG, CH
    CHENG, YC
    PHARMACOLOGIST, 1976, 18 (02): : 118 - 118
  • [38] Ribonucleotide reductase: target therapy for human disease
    Gallicchio, VS
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (06) : 659 - 673
  • [39] Flavonoids as protectors against doxorubicin cardiotoxicity:: Role of iron chelation, antioxidant activity and inhibition of carbonyl reductase
    Kaiserova, Helena
    Simunek, Tomas
    van der Vijgh, Wim J. F.
    Bast, Aalt
    Kvasnickova, Eva
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2007, 1772 (09): : 1065 - 1074
  • [40] EFFECTS OF IRON, COPPER AND ZINC ON THE ACTIVITY OF RIBONUCLEOTIDE REDUCTASE IN NORMAL AND LEUKEMIC HUMAN-LYMPHOCYTES
    OBLENDER, M
    CARPENTIERI, U
    CLINICAL RESEARCH, 1990, 38 (01): : A60 - A60